Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Claret says it latest fund will have larger focus on European life sciences

European firm Claret Capital Partners has raised €575 million in its latest round, dubbed Fund IV, and a sizable portion will be lent out to local biotech companies and manufacturers. Roughly one third of the ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Finance & Markets

More from Monday 7 September →